These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7835210)

  • 1. Effect of aging on plasma 1,5-anhydroglucitol levels in humans and rats.
    Funasako M; Taniji M; Fujimoto K; Ohata M; Higashimoto Y; Uetani K; Suruda T; Nakai S; Fujimoto H; Sakagami Y
    Diabetes Res Clin Pract; 1994 Aug; 25(1):35-41. PubMed ID: 7835210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions.
    Dungan KM
    Expert Rev Mol Diagn; 2008 Jan; 8(1):9-19. PubMed ID: 18088226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control.
    Yamanouchi T; Akanuma Y
    Diabetes Res Clin Pract; 1994 Oct; 24 Suppl():S261-8. PubMed ID: 7859616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients.
    Yamanouchi T; Akanuma H; Nakamura T; Akaoka I; Akanuma Y
    Diabetologia; 1988 Jan; 31(1):41-5. PubMed ID: 3350220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker.
    Buse JB; Freeman JL; Edelman SV; Jovanovic L; McGill JB
    Diabetes Technol Ther; 2003; 5(3):355-63. PubMed ID: 12828817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control.
    Stickle D; Turk J
    Am J Physiol; 1997 Oct; 273(4):E821-30. PubMed ID: 9357814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reference intervals for serum 1,5-anhydroglucitol of a population with normal glucose tolerance in Jiangsu Province.
    Chen C; Wang X; Tan Y; Yang J; Yuan Y; Chen J; Guo H; Wang B; Sun Z; Wang Y
    J Diabetes; 2020 Jun; 12(6):447-454. PubMed ID: 31846192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes.
    Wang Y; Yuan Y; Zhang Y; Lei C; Zhou Y; He J; Sun Z
    Acta Diabetol; 2017 May; 54(5):425-431. PubMed ID: 27896445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma 1,5-anhydro-D-glucitol as new clinical marker of glycemic control in NIDDM patients.
    Yamanouchi T; Minoda S; Yabuuchi M; Akanuma Y; Akanuma H; Miyashita H; Akaoka I
    Diabetes; 1989 Jun; 38(6):723-9. PubMed ID: 2656341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.
    Bai Y; Yang R; Song Y; Wang Y
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):220-225. PubMed ID: 29270924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new method of quantitating serum and urinary levels of 1,5-anhydroglucitol in insulin-dependent diabetes mellitus.
    Namba N; Watanabe F; Tokuda M; Mino M; Furuya E
    Diabetes Res Clin Pract; 1994 May; 24(1):55-61. PubMed ID: 7924887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum 1,5-anhydroglucitol levels slightly increase rather than decrease after a glucose load in subjects with different glucose tolerance status.
    Su H; Ma X; Yin J; Wang Y; He X; Bao Y; Zhou J; Jia W
    Acta Diabetol; 2017 May; 54(5):463-470. PubMed ID: 28210869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic quantification of 1,5-anhydro-D-glucitol: evaluation and clinical application.
    Phillipou G; James SK; Frith RG; Farrant RK; Phillips PJ
    Clin Chem; 1994 Jul; 40(7 Pt 1):1322-6. PubMed ID: 8013107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol.
    Yamanouchi T; Moromizato H; Shinohara T; Minoda S; Miyashita H; Akaoka I
    Metabolism; 1992 Aug; 41(8):862-7. PubMed ID: 1640864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is serum anhydroglucitol an alternative to the oral glucose tolerance test for diabetes screening? The Mauritius Noncommunicable Diseases Study Group.
    Robertson DA; Alberti KG; Dowse GK; Zimmet P; Tuomilehto J; Gareeboo H
    Diabet Med; 1993; 10(1):56-60. PubMed ID: 8435989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography/mass spectrometry in blood plasma of diabetic patients.
    Pitkänen E
    Clin Chim Acta; 1996 Jul; 251(1):91-103. PubMed ID: 8814353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New diagnostic tests for diabetes mellitus. 1,5-anhydroglucitol].
    Yamanouchi T; Akaoka I; Akanuma Y
    Nihon Rinsho; 1989 Nov; 47(11):2472-6. PubMed ID: 2601059
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism for acute reduction of 1,5-anhydroglucitol in rats treated with diabetogenic agents.
    Yamanouchi T; Akaoka I; Akanuma Y; Akanuma H; Miyashita E
    Am J Physiol; 1990 Mar; 258(3 Pt 1):E423-7. PubMed ID: 2138419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of serum 1,5-anhydroglucitol in uremic and diabetic patients by liquid chromatography/mass spectrometry.
    Niwa T; Dewald L; Sone J; Miyazaki T; Kajita M
    Clin Chem; 1994 Feb; 40(2):260-4. PubMed ID: 8313603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of plasma 1,5-anhydroglucitol analysis in the diagnosis of diabetes mellitus].
    Yamanouchi T; Akaoka I
    Nihon Rinsho; 1990 Dec; 48 Suppl():374-80. PubMed ID: 2086911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.